34
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Glutathione S -transferase Genotype and p53 Mutations in Adenocarcinoma of the Small Intestine

, , , , , , , & show all
Pages 845-849 | Published online: 08 Jul 2009

  • Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahiens W, Eriksson M, et al. Medical risk factors for small-bowel adenocarcinoma with focus on Crohn disease: a European populationbased case-control study. Scand J Gastroenterol 2001;3 6:641-6.
  • Lewis JD, Deren JJ, Lichtenstein GR. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am 1999;28:459-77.
  • Munkholm P, Langholz B, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-23.
  • Arber N, Neugut AI, Weinstein IB, Holt P. Molecular genetics of small bowel cancer. Cancer Epidemiol Biomarkers Prev 1997;6:745-8.
  • Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev 1994; 3:205-7.
  • Kaerlev L, Teglbjaerg PS, Sabroe S, Kolstad HA, Ahrens W, Eriksson M, et al. Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center case-control study. Cancer Causes Control 2000; 11:791-7.
  • Sellner F. Investigations on the significance of the adenomacarcinoma sequence in the small bowel. Cancer 1990;66:702-15.
  • Vogelstein B, Kinzler KW. Carcinogens leave fingerprints. Nature 1992;355:209-10.
  • Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Nad Acad Sci USA 1991;88:10124-8.
  • Bressac B, Kew M, Wands J, Oztuik M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991;350:429-31.
  • Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;3 50:427-8.
  • Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T, et al. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 1992;52:734-6.
  • Takahashi T, Takahashi T, Suzuki H, Hida T, Sekido Y, Ariyoshi Y, et al. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 1991;6:1775-8.
  • Arai M, Shimizu S, Imai Y, Nakatsuru Y, Oda H, Oohara T, et al. Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer 1997;70390-5.
  • Rashid A, Hamilton SR. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 1997;! 13:127-35.
  • Sutler T, Arber N, Moss SF, Findling RI, Neugut AI, Weinstein IB, et al. Frequent K-ras mutations in small bowel adenocarcinomas. Dig Dis Sci 1996;41:115-8.
  • Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? Revisited! J Pathol 1994; 172:1-4.
  • d'Errioc A, Taiolo E, Chen X, Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1996; 1:149-73.
  • Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTMl genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993;14:1821-4.
  • Houlston RS, Tomlinson IPM. Polymorphisms and colorectal tumor risk. Gastroenterology 2001; 121:282-301.
  • Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, et al. p53 mutations, ras mutations, and p55-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 1991;51:4090-6.
  • Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 1996;144: 207-13.
  • Yang Q, Khoury MJ, Flanders WD. Sample size requirements in case-only designs to detect gene- environment interaction. Am J Epidemiol 1997; 146:713-20.
  • Garte S, Gaspari L, Alexandrie A-K, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in normal control populations. Cancer Epidemiol Biomarkers Prev 2001; 10:1239-48.
  • Neugut AI, Santos J. The association between cancers of the small and large bowel. Cancer Epidemiol Biomarkers Prev 1993;2:551-3.
  • Soussi T. The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. Mol Med Today 1996;2:32-7.
  • Welsh JA, Castren K, Vahakangas KH. Single-strand conformation polymorphism analysis to detect p53 mutations: characterization and development of controls. Clin Chem 1997; 43: 2251-5.
  • Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB, et al. The human glutathione S-transferases: a case-control study of the incidence of the GSTl O phenotype in patients with adenocarcinoma. Carcinogenesis 1991;12:25-8.
  • World Health Organisation: Pathology and genetics. Tumours of the digestive system. In: Hamilton SR, Aaltonen LA, editors. Lyon: IARC Press; 2000. p. 70-74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.